Breaking News

Interesting Stocks To Watch - Oct. 24: MOH, QCOR, PNRA, DHX, LL, RFMD, ALXN

What makes these stocks interesting?

Chip maker RF Micro Devices Inc. (RFMD) reported better-than-expected adjusted profit for the second quarter and issued financial outlook for the third quarter, above Street expectations.

- Sees Q3 adj. EPS to be $0.06. Consensus - $0.04/Shr.

- Projects Q3 revenues of about $245 mln. Consensus - $217.75 mln.

***

Gilead Sciences Inc. (GILD) reported third-quarter adjusted earnings that topped analysts' estimate.

- Q3 net income was $675.5 mln or $0.85/Shr versus $741.1 mln or $0.95/Shr last year.

- Q3 adjusted net income was $788.9 mln or $1.00/Shr versus $795.2 mln or $1.02/Shr last year. Consensus - $0.94/Shr.

- Q3 total revenues grew 14% to $2.43 bln from $2.12 bln last year. Consensus - $2.34 bln.

***

Questcor Pharmaceuticals Inc. (QCOR) reported higher profit for the third quarter, boosted by increased sales.

- Q3 EPS rose to $0.91 from $0.35 last year.

- Q3 net income was $55.69 mln versus $22.85 mln last year.

- Q3 adj. EPS was $0.97. Consensus - $0.77/Shr.

- Q3 net sales grew to $140.34 mln from $59.82 mln last year. Consensus - $128.81 mln.

***

Fortune Brands Home & Security Inc. (FBHS) reported an upsurge in third-quarter profit and lifted its fiscal 2012 earnings outlook.

- Raises FY12 adj. EPS target to $0.86 - $0.88 from prior view of $0.77 - $0.87. Consensus - $0.84/Shr.

***

Amgen Inc. (AMGN) reported a sharp increase in third-quarter profit, reflecting sustained sales growth of key arthritis drug Enbrel, bone loss therapy Xgeva, and contribution from growth phase drug Sensipar/Mimpara used to treat hyperparathyroidism.

- Lifts FY12 adj. EPS target to $6.50 - $6.60 from prior outlook range of $6.20 - $6.35. Consensus - $6.35/Shr.

- Raises FY12 revenue guidance to $17.2 bln - $17.3 bln from prior view of $16.9 bln - $17.2 bln. Consensus - $17.04 bln.

***

Costamare Inc. (CMRE) reported higher profit for the third quarter, helped by increased revenues.

- Q3 net income was $17.4 mln or $0.29/Shr versus $12.5 mln or $0.18/Shr last year.

- Q3 adj. net income was $30.9 mln or $0.51/Shr versus $20.9 mln or $0.31/Shr last year. Consensus - $0.27/Shr.

- Q3 voyage revenues rose to $99.89 mln from $94.89 mln last year.

- Q3 voyage revenues, adjusted on cash basis, was $107.66 mln, up from $97.81 mln last year. Consensus - $97.67 mln.

***

Polycom Inc. (PLCM) reported better-than-expected results for the third quarter.

- Q3 net loss was $14.09 mln or $0.08/Shr versus profit $23.72 mln or $0.13/Shr.

- Q3 adj. net income was $17.24 mln or $0.10/Shr. Consensus - $0.08/Shr.

- Q3 total revenues declined to $335.39 mln from $355.27 mln last year. Consensus - $331.06 mln.

***

Retail bakery-cafes operator Panera Bread Co. (PNRA) reported better-than-expected results for the third quarter, reflecting improved margins and double-digit revenue growth.

- Lifts Q4 EPS target to $1.72 - $1.74 from prior outlook of $1.66 - $1.70. Consensus - $1.70/Shr.

- Raises FY12 EPS outlook to $5.86 - $5.88 from prior view of $5.72 - $5.78. Consensus - $5.80/Shr.

- Projects FY13 EPS in the range of $6.85 - $7.00. Consensus - $6.91/Shr.

***

Fiber optic components supplier Alliance Fiber Optic Products Inc. (AFOP) reported higher profit for the third quarter, helped by strong customer demand.

- Expects "sales in the remaining quarter of 2012 to be at a similar level as Q3 and result in another record year for AFOP in revenue and operating profits."

***

Molina Healthcare Inc. (MOH) reported better-than-expected results for the third-quarter.

- Q3 net income was $3.4 mln or $0.07/Shr versus $19.0 mln or $0.41/Shr last year. Consensus - loss $0.11/Shr.

- Q3 total revenues grew 31% to $1.54 bln from $1.18 bln last year. Consensus - $1.51 bln.

***

Bridge Capital Holdings (BBNK) reported an increase in third-quarter profit, reflecting the steady expansion of its customer base.

- Q3 EPS was $0.29 versus $0.15 last year. Consensus - $0.21/Shr.

- Q3 net income rose to $4.36 mln from $2.20 mln last year.

- Q3 net interest income after provision for credit losses was $15.2 mln versus $11.4 mln last year.

- Q3 non-interest income was $3.79 mln versus $3.26 mln last year. Consensus - $14.97 mln.

***

Barrett Business Services Inc. (BBSI) reported higher profit for the third quarter and issued earnings outlook for the fourth quarter.

- Projects Q4 EPS in the range of $0.75 - $0.78. Consensus - $0.67/Shr.

- Expects Q4 gross revenues to range between $585 mln and $590 mln.

***

Electric utility ITC Holdings Corp. (ITC) reported an increase in third-quarter profit, reflecting higher revenues.

- Lifts FY12 opt. EPS target to $4.10 - $4.15 from prior view of $3.95 - $4.05. Consensus - $4.03/Shr.

***

IBERIABANK Corp. (IBKC) reported higher profit for the third quarter, reflecting increased net interest income and stable net interest margin.

- Q3 EPS was $0.73 versus $0.54 last year. Consensus - $0.56/Shr.

- Q3 net income rose to $20.8 mln from $16.1 mln last year.

- Q3 net interest income was $96.7 mln versus $90.9 mln last year.

- Q3 net interest income (TE) was $99.1 mln versus $93.3 mln last year. Consensus - $138.34 mln.

***

Silicon Laboratories Inc. (SLAB) expects fourth-quarter revenue to be in the range of $145 mln - $150 mln. Consensus - $142.30 mln.

***

Boeing Co. (BA) now projects FY12 GAAP EPS in the range of $4.80 - 4.95. Consensus - $4.73/Shr.

Now expects FY12 revenue in the range of $80.5 bln - $82.0 bln. Consensus - $80.65 bln.

***

Tupperware Brands Corp. (TUP) sees Q4 EPS in the range of $1.28 - $1.33.

- Expects FY12 EPS to range between $3.38 and $3.43. Consensus - $1.64/Shr.

- Lifts high end of FY12 adj. EPS outlook range by 8 cents versus the prior guidance range. Consensus - 4.89/Shr.

***

Dice Holdings Inc. (DHX) expects Q4 net income to be $8.7 mln and FY12 net income to be $37.6 mln.

***

Lumber Liquidators (LL) lifts FY12 EPS target to $1.53 - $1.59 from the prior view of $1.30 - $1.42. Consensus - $1.46/Shr.

- Raises FY12 net sales guidance to $791 mln - $799 mln from prior outlook of $750 mln - $775 mln. Consensus - $778.25 mln.

***

Alexion Pharmaceuticals Inc. (ALXN) raises FY12 adj. EPS target to $1.99 - $2.04 from previous outlook of $1.78 - $1.88. Consensus - $1.90/Shr.

- Lifts FY12 revenue guidance to $1.120 bln - $1.130 bln from prior view of $1.110 bln - $1.125 bln. Consensus - $1.13 bln.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Breaking News